High-throughput sample prep market seen reaching $1.89 billion by 2030

The high-throughput sample preparation and reagents market is expected to grow from $1.19 billion in 2026 to $1.89 billion by 2030, driven by rising demand for automation in genomics, drug discovery and clinical testing. North America led the market in 2025, while Asia-Pacific is projected to post the fastest growth.

Why it matters: - High-throughput sample preparation and reagents are becoming core infrastructure for labs that need faster, more reproducible testing at scale. - The market outlook signals more spending on automation, robotics and integrated workflows across diagnostics, research and biopharma. - Rising infectious-disease testing needs are adding pressure on labs to process larger sample volumes quickly.

What happened: - The Business Research Company projected the market will rise from $1.06 billion in 2025 to $1.19 billion in 2026. - The report forecast the market will reach $1.89 billion by 2030. - The report pegged the 2026-2030 compound annual growth rate at 12.3%. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - The market covers technologies and consumables used to process large numbers of biological samples in parallel for analytical and diagnostic work. - The systems combine automation, robotics and specialized chemical formulations. - Common workflows include nucleic acid extraction, protein isolation and sample purification. - The recent growth period was driven by genomic research, molecular biology, clinical diagnostics, disease screening, pharmaceutical research, drug discovery, automated lab equipment and academic research. - The forecast period is expected to benefit from precision medicine, personalized healthcare, high-throughput screening in drug development, biopharmaceutical production pipelines, robotics in lab workflows and faster diagnostic turnaround times. - The report flagged fully automated liquid handling and robotic sample processing platforms as a major trend. - Other expected trends include scalable genomics and proteomics workflows, microfluidic sample preparation, integrated reagent kits and standardized consumables for automated high-volume testing. - The report said market coverage includes Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, and the Middle East and Africa. - The report also included market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, hotspots infographics, and updated graphics and tables.

Between the lines: - The market’s growth story is less about one product category and more about the push to remove manual steps from lab operations. - Infectious disease surveillance and precision medicine are creating demand for the same underlying capability: faster sample processing with fewer errors. - The regional split suggests mature demand in North America and faster infrastructure buildout in Asia-Pacific. - The report cited WHO data showing unprecedented dengue transmission in 2024, with 14,434,584 cases, 7,718,585 laboratory-confirmed cases, 52,738 severe cases and 11,201 deaths across all six WHO regions.

What's next: - Demand is likely to rise as clinical labs, research teams and manufacturers expand automated workflows. - The strongest growth should come from tools that improve throughput, reproducibility and turnaround time. - More adoption of integrated kits and robotic platforms could reduce manual labor and standardize testing across sites. - More information is available in the full report and a free sample of the report.

The bottom line: - The market is moving from niche lab support to essential automation infrastructure, with double-digit growth expected through 2030.